Enhanced, sialoadhesin-dependent uptake of guillain-barré syndrome-associated Campylobacter jejuni strains by human macrophages

Infection and Immunity

Volumn 81, Issue 6, 2013, Pages 2095-2103

  Heikema, Astrid P ^a   Koning, Roman I ^b   Rico, Sharon Duarte dos Santos ^a   Rempel, Hans ^c   Jacobs, Bart C ^a   Endtz, Hubert P ^a   van Wamel, Willem J B ^a   Samsom, Janneke N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; EPITOPE; GANGLIOSIDE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; SIALIC ACID; SIALOADHESIN;

ARTICLE; BACTERIAL GROWTH; CAMPYLOBACTER ENTERITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; ENDOCYTOSIS; GUILLAIN BARRE SYNDROME; HUMAN; HUMORAL IMMUNITY; INTERNALIZATION; MACROPHAGE; MOLECULAR RECOGNITION; NONHUMAN; PATTERN RECOGNITION; PH; PRIORITY JOURNAL; PROTEIN BINDING;

ANTIBODIES, BACTERIAL; BACTERIAL ADHESION; CAMPYLOBACTER JEJUNI; CELLS, CULTURED; CROSS REACTIONS; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MOLECULAR MIMICRY; PHAGOCYTOSIS; SIALIC ACID BINDING IG-LIKE LECTIN 1;

EID: 84877795566     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01437-12     Document Type: Article

References (34)

1. Jacobs BC, Hazenberg MP, van Doorn PA, Endtz HP, van der Meché FGA. 1997. Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J. Infect. Dis. 175:729-733.
2. Yuki N, Taki T, Handa S. 1996. Antibody to GalNAc-GD1a and GalNAc- GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis. J. Neuroimmunol. 71:155-161.
3. Hughes RAC, Hadden RD, Gregson NA, Smith KJ. 1999. Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol. 100:74-97.
4. Carpo M, Pedotti R, Allaria S, Lolli F, Mata S, Cavaletti G, Protti A, Pomati S, Scarlato G, Nobile-Orazio E. 1999. Clinical presentation and outcome of Guillain-Barré and related syndromes in relation to antiganglioside antibodies. J. Neurol. Sci. 168:78-84.
5. Jacobs BC, Van Doorn PA, Schmitz PIM, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkaas H, Van der Meché FGA. 1996. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40:181-187.
6. Yuki N. 1997. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain- Barré syndrome and Miller Fisher syndrome. J. Infect. Dis. 176:S150-153.
7. Jacobs BC, Rothbarth PH, van der Meché Herbrink FGAP, Schmitz PIM, De Klerk MA, van Doorn PA. 1998. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 51:1110-1115.
8. Aspinall GO, McDonald AG, Raju TS, Pang H, Kurjanczyk LA, Penner JL, Moran AP. 1993. Chemical structure of the core region of Campylobacter jejuni serotype O:2 lipopolysaccharide. Eur. J. Biochem. 213:1029-1037.
9. Moran AP, Rietschel ET, Kosunen TU, Zahringer U. 1991. Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J. Bacteriol. 173:618-626.
10. Gilbert M, Karwaski Bernatchez M-FS, Young NM, Taboada E, Michniewicz J, Cunningham Wakarchuk A-MWW. 2002. The genetic bases for the variation in the lipo-oligosaccharide of the mucosal pathogen, Campylobacter jejuni. Biosynthesis of sialylated ganglioside mimics in the core oligosaccharide. J. Biol. Chem. 277:327-337.
11. Godschalk PC, Kuijf ML, Li J, St. Michael F, Ang CW, Jacobs BC, Karwaski MF, Brochu D, Moterassed A, Endtz HP, van Belkum A, Gilbert M. 2007. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes. Infect. Immun. 75:1245-1254.
12. Louwen R, Heikema A, van Belkum A, Ott A, Gilbert M, Ang W, Endtz HP, Bergman MP, Nieuwenhuis EE. 2008. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect. Immun. 76:4431-4438.
13. Mortensen NP, Kuijf ML, Ang CW, Schiellerup P, Krogfelt KA, Jacobs BC, van Belkum A, Endtz HP, Bergman MP. 2009. Sialylation of Campylobacter jejuni lipooligosaccharides is associated with severe gastroenteritis and reactive arthritis. Microbes Infect. 11:988-994.
14. Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC, Luider TM, Endtz HP, Nieuwenhuis EE, Jacobs BC. 2010. TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation. J. Immunol. 185:748-755.
15. Bax M, Kuijf ML, Heikema AP, van Rijs W, Bruijns SC, Garcia-Vallejo JJ, Crocker PR, Jacobs BC, van Vliet SJ, van Kooyk Y. 2011. Campylobacter jejuni lipooligosaccharides modulate dendritic cell-mediated T cell polarization in a sialic acid linkage-dependent manner. Infect. Immun. 79:2681-2689.
16. Godschalk PCR, Heikema AP, Gilbert M, Komagamine T, Ang CW, Glerum J, Brochu D, Li J, Yuki N, Jacobs BC, van Belkum A, Endtz HP. 2004. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barre syndrome. J. Clin. Investig. 114: 1659-1665.
17. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome. Proc. Natl. Acad. Sci. U. S. A. 101:11404-11409.
18. Halstead SK, Zitman FM, Humphreys PD, Greenshields K, Verschuuren JJ, Jacobs BC, Rother RP, Plomp JJ, Willison HJ. 2008. Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. Brain 131:1197-1208.
19. Avril T, Wagner ER, Willison HJ, Crocker PR. 2006. Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides. Infect. Immun. 74:4133-4141.
20. Heikema AP, Bergman MP, Richards H, Crocker PR, Gilbert M, Samsom JN, van Wamel WJ, Endtz HP, van Belkum A. 2010. Characterization of the specific interaction between sialoadhesin and sialylated Campylobacter jejuni lipooligosaccharides. Infect. Immun. 78:3237-3246.
21. Rempel H, Calosing C, Sun B, Pulliam L. 2008. Sialoadhesin expressed on IFN-induced monocytes binds HIV-1 and enhances infectivity. PLoS One 3:e1967. doi:10.1371/journal.pone.0001967.
22. Parkhill J, Wren BW, Mungall K, Ketley JM, Churcher C, Basham D, Chillingworth T, Davies RM, Feltwell T, Holroyd S, Jagels K, Karlyshev AV, Moule S, Pallen MJ, Penn CW, Quail MA, Rajandream MA, Rutherford KM, van Vliet AH, Whitehead S, Barrell BG. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
23. Crocker PR, Kelm S, Dubois C, Martin B, McWilliam AS, Shotton DM, Paulson JC, Gordon S. 1991. Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J. 10:1661-1669.
24. Heyningen SV. 1974. Cholera toxin: interaction of subunits with ganglioside GM1. Science 183:656-657.
25. Rinaldi S, Brennan KM, Goodyear CS, O'Leary C, Schiavo G, Crocker PR, Willison HJ. 2009. Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. Glycobiology 19:789-796.
26. Stintzi A, Marlow D, Palyada K, Naikare H, Panciera R, Whitworth L, Clarke C. 2005. Use of genome-wide expression profiling and mutagenesis to study the intestinal lifestyle of Campylobacter jejuni. Infect. Immun. 73:1797-1810.
27. Corcionivoschi N, Clyne M, Lyons A, Elmi A, Gundogdu O, Wren BW, Dorrell N, Karlyshev AV, Bourke B. 2009. Campylobacter jejuni cocultured with epithelial cells reduces surface capsular polysaccharide expression. Infect. Immun. 77:1959-1967.
28. Malik-Kale P, Parker CT, Konkel ME. 2008. Culture of Campylobacter jejuni with sodium deoxycholate induces virulence gene expression. J. Bacteriol. 190:2286-2297.
29. Jones C, Virji M, Crocker PR. 2003. Recognition of sialylated meningococcal lipopolysaccharide by siglecs expressed on myeloid cells leads to enhanced bacterial uptake. Mol. Microbiol. 49:1213-1225.
30. Delputte PL, Van Breedam W, Barbe F, Van Reeth K, Nauwynck HJ. 2007. IFN-alpha treatment enhances porcine arterivirus infection of monocytes via upregulation of the porcine arterivirus receptor sialoadhesin. J. Interferon Cytokine Res. 27:757-766.
31. Huizinga R, Easton AS, Donachie AM, Guthrie J, van Rijs W, Heikema A, Boon L, Samsom JN, Jacobs BC, Willison HJ, Goodyear CS. 2012. Sialylation of Campylobacter jejuni lipo-oligosaccharides: impact on phagocytosis and cytokine production in mice. PLoS One 7:e34416. doi: 10.1371/journal.pone.0034416.
32. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7:255-266.
33. You Y, Myers RC, Freeberg L, Foote J, Kearney JF, Justement LB, Carter RH. 2011. Marginal zone B cells regulate antigen capture by marginal zone macrophages. J. Immunol. 186:2172-2181.
34. Delputte PL, Van Gorp H, Favoreel HW, Hoebeke I, Delrue I, Dewerchin H, Verdonck F, Verhasselt B, Cox E, Nauwynck HJ. 2011. Porcine sialoadhesin (CD169/Siglec-1) is an endocytic receptor that allows targeted delivery of toxins and antigens to macrophages. PLoS One 6:e16827. doi:10.1371/journal.pone.0016827.